Botox cuts women’s chances of an orgasm
IT’S news that could well have women furrowing their brows – if they still can.
Researchers have found that those who have Botox treatment to smooth out facial wrinkles are less likely to achieve orgasms.
Injections of the toxic substance paralyse nerves, making it difficult to produce the full range of facial expressions.
Psychologists at Cardiff University have discovered that, as a result, women find it more harder to communicate to lovers that they are enjoying sex. This, the researchers say, affects performance between the sheets and blunts the woman’s feeling of physical enjoyment.
Dr Michael Lewis, who led the research, explained that just as people find it difficult to feel ecstatically happy without actually smiling, so people struggle to reach orgasm without having full control of the muscles in their face. He said: ‘Facial expressions associated with orgasm utilise the same muscles targeted in typical botulinum toxin cosmetic treatments. The predicted consequence of having treatment is that women may feel an orgasm to a lesser extent and may find it harder to reach climax.
‘Analysis from our study suggests that’s what is happening.’
The study involved 36 women, 24 of whom had been treated with botulinum toxin, measuring their Female Sexual Function Index Orgasm Satisfaction Score.
Those whose frown lines had been injected reported a notable drop in their satisfaction score.
Writing in the journal Scientific Reports, Dr Lewis said: ‘Reduction of mobility of these muscles may interfere with the expression and feedback of excitement during sexual activity. The current research provides support for this hypothesis in that participants reported that, following BTX treatment, there was a decrease in sexual function: in particular, orgasms were harder to achieve and less satisfying.’
He added: ‘The results suggest that the facial expressions do not occur simply to communicate pleasure. They are an integral part of the feeling of pleasure and are important in the process of achieving orgasm. This demonstrates an important role for facial feedback within sexual intercourse and it is potentially a significant negative impact from BTX treatment.’